You are here: All Products  > Fosun Pharma Acquires Cancer Drug Candidate from US-based Kolltan

Fosun Pharma Acquires Cancer Drug Candidate from US-based Kolltan

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products